Clinical Trial Update: Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

View source ↗

Summary

Clinical trial update examining the efficacy, safety, and use of Nuwiq, Octanate, and Wilate in previously untreated and minimally treated Haemophilia A patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• Nuwiq (recombinant factor VIII concentrate)
• Octanate
• Wilate (von Willebrand factor/factor VIII concentrate)

Snippet

Sponsor: Octapharma | Conditions: Haemophilia A | Status: RECRUITING